Latest papers

Intravenous immunoglobulin in Rh hemolytic disease of newborn.

Severe ABO hemolytic disease of newborn with a positive direct antiglobulin test

Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of Newborn.

Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.

Transfusion in the age of molecular diagnostics.

Lutheran.

MNS blood group system: a review.

Rh D foeto-maternal alloimmunization prophylaxis with anti-D immunoglobulins reviewed in the era of foetal RHD genotyping.

Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).

The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.

Diagnosis and Management of Neonatal Alloimmune Thrombocytopenia

The changing face of haemolytic disease of the newborn.

Massive fetomaternal hemorrhage: clearance of fetal red blood cells after intravenous anti-D prophylaxis monitored by flow cytometry.

Erythrophagocytosis in hemolytic disease of the newborn.

Transfusion medicine illustrated: blocked D phenomenon.

Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial.

One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.

Intravenous immunoglobulin in neonatal rhesus hemolytic disease.

Management of rhesus alloimmunization in pregnancy.

Haemolytic disease of the newborn because of rare anti-Vel.